VCEL Stock Analysis: Buy, Sell, or Hold?
VCEL - Vericel Corporation
$40.39
-0.08 (-0.20%)
▼
5d:
+5.48%
30d:
+14.91%
90d:
+24.47%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Get Alerted When VCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VCEL shows positive signals but monitor for confirmation. Market pricing in 3.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: VCEL shows positive signals but monitor for confirmation. Market pricing in 3.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$41.48
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCEL is currently trading at $40.39, which is considered extended relative to its 30-day fair value range of $34.14 to $38.54. The stock's valuation (Forward PE: 47.4) is in line with its historical norms (52.1). Remarkably, the market is currently pricing in an annual earnings decline of 3.1% over the next few years. This pessimistic expectation contrasts with the company's recent 18.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, VCEL is showing sideways momentum. The price is approaching resistance at $41.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VCEL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $55.43 (+37.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VCEL is showing sideways momentum. The price is approaching resistance at $41.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VCEL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $55.43 (+37.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$34.14 -
$38.54
Company Quality Score
57/100
(HOLD)
Options IV Signal
14th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
69.2%
Protect Your Profits
VCEL is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 14th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.2% below Wall St target ($55.43)
Trading Range Analysis
30-Day Trading Range
$34.14 -
$38.54
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.78
(6.9%)
Support & Resistance Levels
Support Level
$36.43
Resistance Level
$41.11
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
47.41
Wall Street Target
$55.43
(+37.2%)
Revenue Growth (YoY)
30.1%
Earnings Growth (YoY)
18.9%
Profit Margin
7.3%
Valuation Discount vs History
-3.1% cheaper
PE vs Historical
47.4 vs 52.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.1%
(market-implied from PE analysis)
1-Year Target
$39.14
(-3%)
2-Year Target
$37.92
(-6%)
3-Year Target
$36.75
(-9%)
3-Yr Target (if PE normalizes)
(PE: 47→52)
$40.39
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 47.4, Growth: 88.5%)
$136.32
(+238%)
Base:
(SPY PE: 21.8, Growth: 88.5%)
$62.63
(+55%)
Bear:
(PE: 18.5, Growth: 88.5%)
$53.23
(+32%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (94x PE), but valuation improves significantly next year (47x PE) as earnings recover.
Trailing PE: 94.12 | Current EPS (TTM): $0.43
Bull Case
$88.21
(+118%)
Analyst growth 98.1%, PE expands to 103.5
Base Case
$80.19
(+99%)
Market implied 98.1%, PE stable at 94.1
Bear Case
$27.52
(-32%)
Severe decline -20.0%, PE contracts to 80.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 47.4 to 52.1
Stabilization Target:
$44.39
(+9.9%)
PE Expansion Potential:
+9.9%
Share & Embed Analysis
Last updated: June 24, 2026 3:06 AM ET
Data refreshes hourly during market hours. Next update: 4:06 AM
Data refreshes hourly during market hours. Next update: 4:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Jonathan Mark Hopper
SELL
3472 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
Advanced VCEL Option Strategies
Professional options setups generated by AI based on today's VCEL price and gamma walls.
